Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
Neuropediatrics|February 1, 1994
Intracranial germ cell tumors: a comprehensive update of the European dataG Calaminus, M Bamberg, M C Baranzelli, et al.
Haematologica|July 16, 1999
The belgian experience in unrelated donor bone marrow transplantation: identification of center experience as an important prognostic factorM F Dresse, M Boogaerts, C Vermylen, et al.
Medical and Pediatric Oncology|March 1, 1996
Mitoxantrone-containing regimen for treatment of childhood acute leukemia (AML) and analysis of prognostic factors: results of the EORTC Children Leukemia Cooperative Study 58872C Béhar, S Suciu, Y Benoit, et al.
Bone Marrow Transplantation|July 25, 1998
Haematopoietic stem cell transplantation for sickle cell anaemia: the first 50 patients transplanted in BelgiumC Vermylen, G Cornu, A Ferster, et al.
Revue Medicale De Bruxelles|June 5, 2001
[Immune deficiencies: diagnosis, management, some perspectives]C M Farber, Y Benoit, K Boven, et al.
European Journal of Cancer (Oxford, England : 1990)|March 28, 1998
Sensitive and reliable detection of genomic imbalances in human neuroblastomas using comparative genomic hybridisation analysisM Van Gele, N Van Roy, A Jauch, et al.
Acta Clinica Belgica|August 18, 2012
Recommendations in the event of a suspected transfusion-related acute lung injury (TRALI)P Van der Linden, M Lambermont, A Dierick, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|May 26, 2021
CNS-3 status remains an independent adverse prognosis factor in children with acute lymphoblastic leukemia (ALL) treated without cranial irradiation: Results of EORTC Children Leukemia Group study 58951N Sirvent, S Suciu, B De Moerloose, et al.
Leukemia|January 28, 2005
A new recurrent inversion, inv(7)(p15q34), leads to transcriptional activation of HOXA10 and HOXA11 in a subset of T-cell acute lymphoblastic leukemiasF Speleman, B Cauwelier, N Dastugue, et al.
Leukemia|September 24, 2010
NOTCH1 and FBXW7 mutations have a favorable impact on early response to treatment, but not on outcome, in children with T-cell acute lymphoblastic leukemia (T-ALL) treated on EORTC trials 58881 and 58951E Clappier, S Collette, N Grardel, et al.
Pageof 9